Abstract

BackgroundFibulin-5 has been considered as a tumor suppressor through inhibiting tumor growth and invasion. Reduced expression of Fibulin-5 is frequently observed in various human cancers. In this study, we investigate the clinical significance of Fibulin-5 and its role in hepatocellular carcinoma (HCC) cell migration and invasion.MethodsThe expression of Fibulin-5 was evaluated by qRT-PCR and immunoblotting in HCC and matched noncancerous tissues. Fibulin-5 was over-expressed or knocked down by a retrovirus-mediated expression plasmid or a specific siRNA in HCC cells. Boyden chamber and Transwell assays were used to test HCC cell migration and invasion. Immunostaining was performed to determine matrix metalloproteinase-7 (MMP-7) expression in HCC specimens. MMP-7 retroviruses and siRNA were used to alter MMP-7 expression in HCC cells.ResultsIn our study, the expression levels of Fibulin-5 protein and mRNA were down-regulated in HCC tissues as compared with those in matched noncancerous tissues. Reduced expression of Fibulin-5 was observed in all HCC cell lines (HepG2, SMMC-7721, MHCC97L, Hep3B, MHCC97H and HCC-LM3) as compare with that in a non-transformed hepatic cell line (LO2). Low expression of Fibulin-5 was significantly correlated with poor prognostic features including multiple tumor nodes, venous infiltration, high Edmondson-Steiner grading and advanced tumor-node-metastasis (TNM) tumor stage. Furthermore, we demonstrated that Fibulin-5 was a novel independent prognostic marker for predicting 5-year survival of HCC patients. Our in vitro studies showed that Fibulin-5 overexpression inhibited HCC cell migration and invasion. While Fibulin-5 knockdown increased the number of migrated and invaded HCC cells. Fibulin-5 negatively regulated MMP-7 abundance in HCC cells. Moreover, the inverse correlation between Fibulin-5 and MMP-7 expressions was observed in HCC tissues. Mechanistically, we disclosed that MMP-7 knockdown reduced the number of migrated and invaded HCC cells. Restoring MMP-7 expression abrogated the suppressive effect of Fibulin-5 on HCC cell migration and invasion in vitro, suggesting that Fibulin-5 exerted its anti-metastatic function, at least in part, by down-regulating the expression of MMP-7 in HCC cells.ConclusionsThese results indicate that Fibulin-5 may serve as a prognostic biomarker and inhibits HCC invasion and metastasis by suppressing MMP-7 expression.

Highlights

  • Fibulin-5 has been considered as a tumor suppressor through inhibiting tumor growth and invasion

  • We found that Fibulin-5 expression in hepatocellular carcinoma (HCC) tissues was prominently lower than that in matched tumoradjacent tissues (P < 0.05, Figure 1A). 20 pairs of tumor tissues and matched adjacent nontumor tissues were subjected to quantitative reverse transcription polymerase chain reaction (qRT-PCR) for Fibulin-5 mRNA

  • We find that Fibulin-5 functions as an independent factor for predicting the 5-year overall survival and disease-free survival of HCC patients

Read more

Summary

Introduction

Fibulin-5 has been considered as a tumor suppressor through inhibiting tumor growth and invasion. We investigate the clinical significance of Fibulin-5 and its role in hepatocellular carcinoma (HCC) cell migration and invasion. In vitro studies showed Fibulin-5 inhibited proliferation and invasion of human bladder cancer cell [11]. Fibulin-5 has been implicated in inhibiting lung cancer metastasis by modulating matrix metalloproteinase (MMP7) expression [12]. These studies indicate that Fibulin-5 probably functions as a suppressor for tumor formation and metastasis. Fibulin-5 expression was found to be stimulated by transforming growth factor (TGF)-beta in mammary epithelial cells (MECs) and its upregulation resulted in MEC invasion and epithelial-mesenchymal transition (EMT) via a MMPdependent mechanism [14]. Fibulin-5 in the initiation and progression of HCC remains poorly understood

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.